Jundishapur Journal of Chronic Disease Care

Published by: Kowsar

Relation of Serum Uric Acid With C-reactive Protein and Ferritin Levels in Patients Undergoing Hemodialysis

Vajihe Biniaz 1 , Mahdi Sadeghi Shermeh 1 , Ali Tayebi 1 , * , Abbas Ebadi 1 , Eghlim Nemati 2 and Hassan Honarvar 3
Authors Information
1 Department of Medical Surgical Nursing, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Department of Nephrology and Urology, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Department of Systems Engineering, Imam Hossein University, Tehran, IR Iran
Article information
  • Jundishapur Journal of Chronic Disease Care: October 01, 2014, 3 (4); e23350
  • Published Online: October 20, 2014
  • Article Type: Research Article
  • Received: April 2, 2014
  • Revised: May 5, 2014
  • Accepted: June 14, 2014
  • DOI: 10.17795/jjcdc.23350

To Cite: Biniaz V, Sadeghi Shermeh M, Tayebi A, Ebadi A, Nemati E, et al. Relation of Serum Uric Acid With C-reactive Protein and Ferritin Levels in Patients Undergoing Hemodialysis, Jundishapur J Chronic Dis Care. 2014 ; 3(4):e23350. doi: 10.17795/jjcdc.23350.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Wang Y, Bao X. Effects of uric acid on endothelial dysfunction in early chronic kidney disease and its mechanisms. Eur J Med Res. 2013; 18: 26[DOI][PubMed]
  • 2. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009; 9: 44[DOI][PubMed]
  • 3. Horigan AE. Fatigue in hemodialysis patients: a review of current knowledge. J Pain Symptom Manage. 2012; 44(5): 715-24[DOI][PubMed]
  • 4. Letchmi S, Das S, Halim H, Zakariah FA, Hassan H, Mat S, et al. Fatigue experienced by patients receiving maintenance dialysis in hemodialysis units. Nurs Health Sci. 2011; 13(1): 60-4[DOI][PubMed]
  • 5. Cleary J, Drennan J. Quality of life of patients on haemodialysis for end-stage renal disease. J Adv Nurs. 2005; 51(6): 577-86[DOI][PubMed]
  • 6. Hajhosseiny R, Khavandi K, Goldsmith DJ. Cardiovascular disease in chronic kidney disease: untying the Gordian knot. Int J Clin Pract. 2013; 67(1): 14-31[DOI][PubMed]
  • 7. Marinelli A, Orlandi L, Stivali G. C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis. Clin Nephrol. 2011; 76(6): 425-34[PubMed]
  • 8. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004; 164(14): 1546-51[DOI][PubMed]
  • 9. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension. 2006; 47(2): 195-202[DOI][PubMed]
  • 10. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009; 53(5): 796-803[DOI][PubMed]
  • 11. Park JT, Kim DK, Chang TI, Kim HW, Chang JH, Park SY, et al. Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant. 2009; 24(11): 3520-5[DOI][PubMed]
  • 12. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005; 68(2): 766-72[DOI][PubMed]
  • 13. Senol E, Ersoy A, Erdinc S, Sarandol E, Yurtkuran M. Oxidative stress and ferritin levels in haemodialysis patients. Nephrol Dial Transplant. 2008; 23(2): 665-72[DOI][PubMed]
  • 14. Kundhal K, Lok CE. Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin Pract. 2005; 101(2)-52[DOI][PubMed]
  • 15. Grainger R, McLaughlin RJ, Harrison AA, Harper JL. Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout. Rheumatology (Oxford). 2013; 52(6): 1018-21[DOI][PubMed]
  • 16. Inaba S, Sautin Y, Garcia GE, Johnson RJ. What can asymptomatic hyperuricaemia and systemic inflammation in the absence of gout tell us? Rheumatology (Oxford). 2013; 52(6): 963-5[DOI][PubMed]
  • 17. Lobo JC, Stockler-Pinto MB, da Nobrega AC, Carraro-Eduardo JC, Mafra D. Is there association between uric acid and inflammation in hemodialysis patients? Ren Fail. 2013; 35(3): 361-6[DOI][PubMed]
  • 18. Krane V, Winkler K, Drechsler C, Lilienthal J, Marz W, Wanner C, et al. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus. Am J Kidney Dis. 2009; 54(5): 902-11[DOI][PubMed]
  • 19. You SA, Wang Q. Ferritin in atherosclerosis. Clin Chim Acta. 2005; 357(1): 1-16[DOI][PubMed]
  • 20. Puntarulo S. Iron, oxidative stress and human health. Mol Aspects Med. 2005; 26(4-5): 299-312[DOI][PubMed]
  • 21. Gorstein J, Sullivan KM, Parvanta I, Begin F. Indicators and methods for cross-sectional surveys of vitamin and mineral status of populations 2007;
  • 22. Numakura K, Satoh S, Tsuchiya N, Saito M, Maita S, Obara T, et al. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival. Transplantation. 2012; 94(2): 145-51[DOI][PubMed]
  • 23. Baradari AG, Emami Zeydi A, Espahbodi F, Shahmohammadi S. Evaluation of serum C-reactive protein level and its related factors in hemodialysis patients in Sari, Iran. Pak J Biol Sci. 2011; 14(10): 595-9[PubMed]
  • 24. Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, et al. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics. 2006; 6(3): 993-1000[DOI][PubMed]
  • 25. Ogino K, Kato M, Furuse Y, Kinugasa Y, Ishida K, Osaki S, et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail. 2010; 3(1): 73-81[DOI][PubMed]
  • 26. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010; 5(8): 1388-93[DOI][PubMed]
  • 27. Muir SW, Harrow C, Dawson J, Lees KR, Weir CJ, Sattar N, et al. Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke. 2008; 39(12): 3303-7[DOI][PubMed]
  • 28. Ziga N, Becic F. Allopurinol effect on values of lipid profile fractions in hyperuricemic patients diagnosed with metabolic syndrome. Mater Sociomed. 2013; 25(3): 167-9[DOI][PubMed]
  • 29. Cicero AF, Rosticci M, Parini A, Baronio C, D'Addato S, Borghi C. Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study. Intern Emerg Med. 2014; 9(6): 655-60[DOI][PubMed]
  • 30. Cerecero P, Hernandez-Prado B, Denova E, Valdes R, Vazquez G, Camarillo E, et al. Association between serum uric acid levels and cardiovascular risk among university workers from the State of Mexico: a nested case-control study. BMC Public Health. 2013; 13: 415[DOI][PubMed]
  • 31. Rambod M, Rafii F. Perceived social support and quality of life in Iranian hemodialysis patients. J Nurs Scholarsh. 2010; 42(3): 242-9[DOI][PubMed]
  • 32. Feng S, Jiang L, Shi Y, Shen H, Shi X, Jin D, et al. Uric acid levels and all-cause mortality in peritoneal dialysis patients. Kidney Blood Press Res. 2013; 37(2-3): 181-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments